Drug discovery teams use spheroids and organoids to measure biological responses and generate data that informs critical go/no-go decisions. But thick 3D samples are difficult to resolve with conventional fluorescence microscopy. Widefield systems collect both in-focus and out-of-focus light across the entire sample depth, causing spectral overlap that blurs multiplexed readouts together.
This whitepaper compares confocal and widefield imaging to show where depth-resolved acquisition addresses the limitations of widefield fluorescence in 3D models. Applications span cell cycle analysis, immune cell killing, multi-spheroid assays, and organoid studies, each acquired under continuous live-cell monitoring.
Download this whitepaper to review
- Which markers stay quantitative when three fluorescence channels run simultaneously
- How spatial resolution clarifies immune cell accumulation in outer spheroid layers
- Where depth-resolved imaging separates a G1 arrest from an optical artifact across a multi-day treatment
